Get started
RocketTickers

Precigen Announces Clearance of IND to Initiate Phase 1/1b Study

Long
Precigen, Inc. (NASDAQ:PGEN)  
RocketTickers  
NASDAQ:PGEN   Precigen, Inc.
Beyond Technical Analysis
1
0
beyondta
PGEN: Precigen, Inc.
2021-10-26 08:05:00
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.